Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.
Saved in:
| Title: | Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. |
|---|---|
| Authors: | Khoury HJ; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia., Collins RH Jr; Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas., Blum W; Department of Hematology, The Ohio State University, Columbus, Ohio., Stiff PS; Department of Medicine, Loyola University, Maywood, Illinois., Elias L; Geron Corporation, Menlo Park, California., Lebkowski JS; Asterias Biotherapeutics Inc, Menlo Park, California., Reddy A; Geron Corporation, Menlo Park, California., Nishimoto KP; Asterias Biotherapeutics Inc, Menlo Park, California., Sen D; Asterias Biotherapeutics Inc, Menlo Park, California., Wirth ED 3rd; Asterias Biotherapeutics Inc, Menlo Park, California., Case CC; Asterias Biotherapeutics Inc, Menlo Park, California., DiPersio JF; Department of Oncology, Washington University School of Medicine, St. Louis, Missouri. |
| Source: | Cancer [Cancer] 2017 Aug 15; Vol. 123 (16), pp. 3061-3072. Date of Electronic Publication: 2017 Apr 14. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28411378 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Khoury+HJ%22">Khoury HJ</searchLink>; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Collins+RH+Jr%22">Collins RH Jr</searchLink>; Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Blum+W%22">Blum W</searchLink>; Department of Hematology, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Stiff+PS%22">Stiff PS</searchLink>; Department of Medicine, Loyola University, Maywood, Illinois.<br /><searchLink fieldCode="AU" term="%22Elias+L%22">Elias L</searchLink>; Geron Corporation, Menlo Park, California.<br /><searchLink fieldCode="AU" term="%22Lebkowski+JS%22">Lebkowski JS</searchLink>; Asterias Biotherapeutics Inc, Menlo Park, California.<br /><searchLink fieldCode="AU" term="%22Reddy+A%22">Reddy A</searchLink>; Geron Corporation, Menlo Park, California.<br /><searchLink fieldCode="AU" term="%22Nishimoto+KP%22">Nishimoto KP</searchLink>; Asterias Biotherapeutics Inc, Menlo Park, California.<br /><searchLink fieldCode="AU" term="%22Sen+D%22">Sen D</searchLink>; Asterias Biotherapeutics Inc, Menlo Park, California.<br /><searchLink fieldCode="AU" term="%22Wirth+ED+3rd%22">Wirth ED 3rd</searchLink>; Asterias Biotherapeutics Inc, Menlo Park, California.<br /><searchLink fieldCode="AU" term="%22Case+CC%22">Case CC</searchLink>; Asterias Biotherapeutics Inc, Menlo Park, California.<br /><searchLink fieldCode="AU" term="%22DiPersio+JF%22">DiPersio JF</searchLink>; Department of Oncology, Washington University School of Medicine, St. Louis, Missouri. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2017 Aug 15; Vol. 123 (16), pp. 3061-3072. <i>Date of Electronic Publication: </i>2017 Apr 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28411378 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.30696 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3061 Titles: – TitleFull: Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Khoury HJ – PersonEntity: Name: NameFull: Collins RH Jr – PersonEntity: Name: NameFull: Blum W – PersonEntity: Name: NameFull: Stiff PS – PersonEntity: Name: NameFull: Elias L – PersonEntity: Name: NameFull: Lebkowski JS – PersonEntity: Name: NameFull: Reddy A – PersonEntity: Name: NameFull: Nishimoto KP – PersonEntity: Name: NameFull: Sen D – PersonEntity: Name: NameFull: Wirth ED 3rd – PersonEntity: Name: NameFull: Case CC – PersonEntity: Name: NameFull: DiPersio JF IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 08 Text: 2017 Aug 15 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1097-0142 Numbering: – Type: volume Value: 123 – Type: issue Value: 16 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |